[95 Report Pages] This market research report identifies Mylan NV, Novartis AG, Amgen, Inc., Becton Dickinson and Company, Bayer AG, and Eli Lilly & Company Ltd as the major vendors operating in the global autoinjectors market. This report also provides a detailed analysis of the market by application (Anaphylaxis, Multiple sclerosis, Rheumatoid arthritis, Diabetes, and Others), product type (Disposable autoinjectors and Reusable autoinjectors), and region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Autoinjectors Market

Infoholic’s market research report predicts that the global autoinjectors market will grow at a CAGR of 17.1% during the forecast period 2018–2024. The raising prevalence of serious medical conditions such as anaphylaxis & other food allergies, advancements in the autoinjectors technology, increasing demand for home healthcare, and the rising need for self-injectors are the factors aiding the growth of the autoinjectors market. Novel formulations of drugs and advancements in drug delivery systems along with favorable government regulations are providing an opportunity for market growth. However, recent product recalls by the companies and the availability of substitutes for autoinjectors are hampering the market growth.

According to the autoinjectors market analysis, in 2017, North America accounts for the largest share of the autoinjectors market, followed by Europe, Asia Pacific, and Rest of the World. More than 65% of the market is occupied by North America, with the US being the major contributor to the market growth.

Competitive Analysis and Key Vendors

The key manufacturers of autoinjectors are concentrating on innovative marketing tactics to expand the reach of their products globally. Increasing awareness campaigns and price reduction of branded devices are among the strategies used by the leading companies to manage intense competition in the market. Many companies are rebranding their autoinjectors with worthwhile reductions in the price. In December 2016, Mylan launched the generic version of EpiPen to provide autoinjectors for customers at lesser prices. This approach ought to help the company in targeting a larger customer pool, thus increasing the company’s customer base in recent years.

 Some of the Autoinjectors Market key vendors are:

• Mylan NV


• Novartis AG


• Amgen, Inc.


• Becton Dickinson and Company


• Bayer AG


• Eli Lilly & Company Ltd


 

The other key players in the market include Ypsomed Holding AG, Biogen Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical, Antares Pharma, Inc., Johnson and Johnson, and AbbVie Inc.

Autoinjectors Market by Product

• Disposable autoinjectors


• Reusable autoinjectors


 

In 2017, the disposable autoinjectors hold dominant market share and is also the fastest growing segment in the market.

Autoinjectors Market by Application

• Anaphylaxis


• Multiple sclerosis


•  Rheumatoid arthritis


• Diabetes


• Others


 

In 2017, the market is dominated by anaphylaxis owing to a high prevalence rate globally. The fastest growing segment of the market is rheumatoid arthritis due to increased development of novel drugs for the treatment of the condition.

Benefits

The report provides detailed information about the usage and adoption of autoinjectors in various regions. With that, key stakeholders can find out the major trends, drivers, investments, and vertical player’s initiatives toward the product adoption in the upcoming years, along with the details of commercial products available in the market. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the autoinjectors market.

Key Stakeholders:

1     Industry Outlook 

1.1        Industry Overview

1.2        Total Addressable Market

2     Report Outline 

2.1        Report Scope

2.2        Report Summary

2.3        Research Methodology

2.4        Report Assumptions

3     Market Snapshot 

3.1        Market Definition – Infoholic Research

3.2        Segmented Addressable Market

3.3        Industry Trends

3.4        Related Markets

3.4.1     Transdermal Drug Delivery

3.4.1.1 Trends in the transdermal drug delivery market

3.4.2     Pulmonary Drug Delivery Systems (PDDS)

3.4.3     Insulin Pumps

4     Market Outlook 

4.1        Cost Comparison of EpiPen and its Alternatives

4.2        Market Segmentation

4.3        Porter 5(Five) Forces

4.4        PEST Analysis

5     Market Characteristics 

5.1        Market Dynamics

5.1.1     Drivers

5.1.1.1 Increasing prevalence of anaphylaxis

5.1.1.2 Rising incidence of chronic disease

5.1.1.3 Increased development biologics/biosimilars

5.1.1.4 Growing demand for home care

5.1.2     Opportunities

5.1.2.1 Increase in healthcare spending

5.1.2.2 Opportunities in the emerging market

5.1.2.3 Favorable government policies

5.1.3     Restraints

5.1.3.1 Competition among major vendors

5.1.3.2 Increased product recall

5.1.3.3 High product pricing

5.2        DRO – Impact Analysis

5.3        Key Stakeholders

6     Applications: Market Size and Analysis 

6.1        Overview

6.2        Anaphylaxis

6.3        Multiple Sclerosis

6.4        Rheumatoid Arthritis

6.5        Diabetes

6.6        Others

7     Product Type: Market Size and Analysis 

7.1        Overview

7.2        Disposable Autoinjectors

7.3        Reusable Autoinjectors

8     Regions: Market Size and Analysis 

8.1        Overview

8.2        North America

8.2.1     Overview

8.3        Europe

8.3.1     Overview

8.4        Asia Pacific

8.4.1     Overview

8.5        Rest of the World

8.5.1     Overview

9   Competitive Landscape 

 

10  Vendors Profile 

10.1     Amgen Inc.

10.1.1  Overview

10.1.2  Geographic Presence

10.1.3  Business Focus

10.1.4  SWOT Analysis

10.1.5  Business Strategies

10.2     Becton Dickinson and Company

10.2.1  Overview

10.2.2  Business Units

10.2.3  Geographic Revenue

10.2.4  Business Focus

10.2.5  SWOT Analysis

10.2.6  Business Strategies

10.3     Mylan N.V.

10.3.1  Overview

10.3.2  Business Segments

10.3.3  Geographic Presence

10.3.4  Business Focus

10.3.5  SWOT Analysis

10.3.6  Business Strategies

10.4     Bayer AG

10.4.1  Overview

10.4.2  Business Units

10.4.3  Geographic Presence

10.4.4  Business Focus

10.4.5  SWOT Analysis

10.4.6  Business Strategies

10.5     Eli Lilly & Company Ltd.

10.5.1  Overview

10.5.2  Business Units

10.5.3  Geographic Revenue

10.5.4  Business Focus

10.5.5  SWOT Analysis

10.5.6  Business Strategies

10.6     Novartis AG

10.6.1  Overview

10.6.2  Business Units

10.6.3  Geographic Presence

10.6.4  Business Focus

10.6.5  SWOT Analysis

10.6.6  Business Strategies

11  Companies to Watch for 

11.1     Ypsomed Holding AG

11.1.1  Overview

11.2     Biogen Pharmaceuticals

11.2.1  Overview

11.3     Pfizer Inc.

11.3.1  Overview

11.3.2  Highlights

11.4     Teva Pharmaceutical Industries Ltd.

11.4.1  Overview

11.5     Antares Pharma Inc.

11.5.1  Overview

11.6     Johnson & Johnson

11.6.1  Overview

11.7     AbbVie Inc.

11.7.1  Overview

Annexure 

Abbreviations